Application of Wilhelm E. Walles, William F. Tousignant and Thomas Houtman, Jr

366 F.2d 786, 54 C.C.P.A. 710
CourtCourt of Customs and Patent Appeals
DecidedOctober 6, 1966
DocketPatent Appeal 7400
StatusPublished
Cited by19 cases

This text of 366 F.2d 786 (Application of Wilhelm E. Walles, William F. Tousignant and Thomas Houtman, Jr) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Application of Wilhelm E. Walles, William F. Tousignant and Thomas Houtman, Jr, 366 F.2d 786, 54 C.C.P.A. 710 (ccpa 1966).

Opinions

SMITH, Judge.

Appealed claims 1-7 were rejected as “unpatentable over” the claims of a patent to Tousignant et al. This rejection was affirmed by the Board of Appeals. We find the rejection to be improper and therefore reverse the decision of the board.

After an extensive prosecution, the appealed claims stood rejected in view of [787]*787the patent previously issued to appellants. While the rejection has been sometimes couched in terms of “double patenting” below, we will first set forth the relationship between the appealed claims and the patent claims before attempting to ascertain the basis for the rejection.

The Applications

The facts are relatively simple and not in dispute. Appellants are the inventors of record in the appealed application 1 and the patent.2 The appealed application results from a division of a parent case. The patent relied upon for the rejection issued on a continuation-in-part application based on the parent case. The parent case is not involved here. No requirement for restriction was made by the Patent Office between the appealed application and the continuation-in-part application and appellants do not claim any benefit here under 35 U.S.C. § 121. The patent is not prior art under 35 U.S.C. § 103 because it is not entitled to an earlier filing date than the appealed application. It is not prior art under 35 U.S.C. § 102(e) because it was filed by the same inventors.

The Inventions

The subject matter defined in the patent claims and the appealed claims may be described as follows. All of the appealed claims define a resin per se.3 All of the patent claims relied on in the rejection define a hair setting composition.4 The patent claims define a hair [788]*788setting composition in which the resin of appealed claims 1-6 provides one component.5

The Rejection

The examiner rejected the appealed claims as “unpatentable over” the patent claims. The examiner’s answer before the board states:

The Examiner’s position, succinctly stated, is that a polymer is not patentable over the same polymer dispersed in water. * * *
******
Applicant firmly maintains that [the patent] * * * is not prior art because the application on appeal takes priority to the filing date of [the patent] * * *. That such a position is untenable is clearly shown by In re Ockert, [44 CCPA 1024, 245 F.2d 467, 114 USPQ 330] * * *:
That if only one inventive concept is present, two patents cannot be granted regardless of the order in which the applications were filed. (Italics added)
******
In summary the Examiner submits that a clear unequivocal case of double patenting has been made out. * * *

The board in its opinion expressly declined to indicate whether the basis of the rejection was “double patenting” or whether its rejection was based on the patent as prior art. The board found instead that the appealed claims and the patent claims claimed the “same invention,” citing 35 U.S.C. § 101; that the claims “differ in scope only;” and that there was no “patentable distinction” between the appealed claims and the patent claims. The board agreed with the examiner’s reasoning and added:

* * * We do not consider such solutions of a soluble polymer to constitute patentably separate and distinct subject matter. * * *
* * * aqueous solutions of the [resin per se] * * * such as those claimed in appellants’ patent, would be apparent to the polymer chemist of no more than ordinary knowledge and skill. * * *

A terminal disclaimer as to the appealed claims was filed but was given no legal effect in overcoming the rejection.

The solicitor in his brief, apparently recognizing the contradiction between the board’s positions — that the appealed claims and the patent claims claimed the “same invention” but also claimed different inventions which were “patentably indistinct” — argues primarily the broader ground that the patent claims and the appealed claims are “patentably indistinct.” However, concerning the terminal disclaimer, the solicitor argues that our decisions in In re Robeson, 331 F.2d 610, 51 CCPA 1271; and In re Kaye, 332 F.2d 816, 51 CCPA 1465, are not controlling because of a difference in “facts.” It is reasoned that in Kaye and Robeson there were “separate inventions” and the claims defined “mutually exclusive subject matter” whereas here the appealed claims and the patent claims differ only in “scope” based upon “the same subject matter.” The solicitor’s brief 6 concludes:

* * * the fact that the appeal claims will dominate the patent claims is a sufficiently important difference to make those decisions \Kaye and Robeson] inapplicable.

[789]*789From this background, only briefly commented on, we must determine what is the basis for the rejection. It is readily apparent that the terms “same invention” and “patentably indistinct” provide little assistance in making this determination.

“Same Invention”

Do the appealed claims and the patent claims define the “same invention ?” We would comment at this point that the patent bar was cautioned some 33 years previously by Stringham, in his book entitled Double Patenting, 22, 24 (1933), as follows:

* * * The term “same invention” is too broad a term to fit in with the law of double patenting, because of the diversity of meanings of “invention.”
* * * -x- * *
The undue breadth of the term “same invention” has occasioned, at least in part, the difficulty which inventors have had in getting proper protection on more than one related achievement. It is not even approximately true to say that the law does not permit more than one patent on the “same invention.” * * *

We think the 1952 Patent Act recognized this warning. The term “invention” as used in the 1952 Patent Act means an “invention or discovery” (35 U.S.C. § 100), or as stated in 35 U.S.C. § 112, it is the “subject matter which the applicant regards as his invention.” Before such “invention” may be patented it must meet the requirements of 35 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Metoprolol Succinate Patent Litigation
494 F.3d 1011 (Federal Circuit, 2007)
AstraZeneca AB v. KV Pharmaceutical Co.
494 F.3d 1011 (Federal Circuit, 2007)
EI DuPont De Nemours and Co. v. Monsanto Co.
903 F. Supp. 680 (D. Delaware, 1995)
In Re Edgar L. Stencel
828 F.2d 751 (Federal Circuit, 1987)
Application of Frederick A. Purdy
393 F.2d 1010 (Customs and Patent Appeals, 1968)
Application of Harry Dudley Wright
393 F.2d 1001 (Customs and Patent Appeals, 1968)
Application of Francis J. Boylan
392 F.2d 1017 (Customs and Patent Appeals, 1968)
Application of Robert Duva
387 F.2d 402 (Customs and Patent Appeals, 1967)
Application of David G. Braithwaite
379 F.2d 594 (Customs and Patent Appeals, 1967)
Application of Charles L. Faust and John E. Clifford
378 F.2d 966 (Customs and Patent Appeals, 1967)

Cite This Page — Counsel Stack

Bluebook (online)
366 F.2d 786, 54 C.C.P.A. 710, Counsel Stack Legal Research, https://law.counselstack.com/opinion/application-of-wilhelm-e-walles-william-f-tousignant-and-thomas-houtman-ccpa-1966.